Geron Corp (GERN): Next-Year EPS Estimate 378.58%
As of 2026-06-04, Geron Corp (GERN) has a next-year EPS growth estimate of 378.58%.
On 2026-05-07, analyst consensus for GERN's next-year EPS growth shifted from 353.33% to 378.58% — a positive change of 25.25 percentage points. The revised estimate has been sustained across 21 subsequent trading sessions. Current-year growth is projected at 82.05%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 378.58%
- EPS growth this year
- 82.05%
- EPS next quarter (est)
- -$0.01
- Last price
- $1.21
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 378.58% | 82.05% | -$0.01 | $1.21 |
| 2026-06-03 | 378.58% | 82.05% | -$0.01 | $1.16 |
| 2026-06-02 | 378.58% | 82.05% | -$0.01 | $1.17 |
| 2026-06-01 | 378.58% | 82.05% | -$0.01 | $1.21 |
| 2026-05-31 | 378.58% | 82.05% | -$0.01 | $1.25 |
| 2026-05-28 | 378.58% | 82.05% | -$0.01 | $1.25 |
| 2026-05-27 | 378.58% | 82.05% | -$0.01 | $1.26 |
| 2026-05-26 | 378.58% | 82.05% | -$0.01 | $1.28 |
| 2026-05-25 | 378.58% | 82.05% | -$0.01 | $1.28 |
| 2026-05-24 | 378.58% | 82.05% | -$0.01 | $1.28 |
| 2026-05-21 | 378.58% | 82.05% | -$0.01 | $1.26 |
| 2026-05-20 | 378.58% | 82.05% | -$0.01 | $1.26 |
| 2026-05-19 | 378.58% | 82.05% | -$0.01 | $1.22 |
| 2026-05-18 | 378.58% | 82.05% | -$0.01 | $1.23 |
| 2026-05-17 | 378.58% | 82.05% | -$0.01 | $1.29 |
| 2026-05-14 | 378.58% | 82.05% | -$0.01 | $1.40 |
| 2026-05-13 | 378.58% | 82.05% | -$0.01 | $1.43 |
| 2026-05-12 | 378.58% | 82.05% | -$0.01 | $1.40 |
| 2026-05-11 | 378.58% | 82.05% | -$0.01 | $1.39 |
| 2026-05-10 | 378.58% | 82.05% | -$0.01 | $1.39 |
| 2026-05-07 | 378.58% | 82.05% | -$0.01 | $1.46 |
| 2026-05-06 | 353.33% | 80.77% | -$0.01 | $1.58 |
| 2026-05-05 | 188.00% | 67.95% | -$0.02 | $1.65 |
| 2026-05-04 | 188.00% | 67.95% | -$0.02 | $1.57 |
| 2026-05-03 | 188.00% | 67.95% | -$0.02 | $1.58 |
| 2026-04-30 | 188.00% | 67.95% | -$0.02 | $1.54 |
| 2026-04-29 | 188.00% | 67.95% | -$0.02 | $1.51 |
| 2026-04-28 | 188.00% | 67.95% | -$0.02 | $1.51 |
| 2026-04-27 | 188.00% | 67.95% | -$0.02 | $1.53 |
| 2026-04-26 | 188.00% | 67.95% | -$0.02 | $1.50 |
Recent News
- Geron: Q1 Earnings SnapshotAssociated Press
- Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business HighlightsGlobeNewswire
- Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026GlobeNewswire
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Geron Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Geron Corp (GERN) has a next-year EPS growth estimate of 378.58%, based on analyst consensus.
When was the latest EPS estimate revision for GERN?▾
The most recent revision occurred on 2026-05-07, when analysts adjusted the next-year EPS growth estimate from 353.33% to 378.58%.
What sector and industry does Geron Corp belong to?▾
Geron Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GERN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Geron Corp (GERN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports